# ğŸ”¥ EVO2 FOOD VALIDATOR - STRATEGIC OVERVIEW

## **WHAT MAKES US UNIQUE (vs. PubMed/Google Scholar)**

### **Existing Tools (PubMed, Google Scholar, Examine.com):**
- âœ… Find papers and studies
- âœ… Show abstracts and dosing
- âŒ **NO biological plausibility scoring**
- âŒ **NO patient-specific recommendations**
- âŒ **NO mechanism validation**
- âŒ **NO treatment line intelligence**

### **Our Tool (Full Stack):**
- âœ… Find papers (via LLM + PubMed)
- âœ… **Evo2 Biological Plausibility Score** (target â†’ pathway â†’ disease)
- âœ… **S/P/E Integration** (sequence/pathway/evidence fusion)
- âœ… **SAE Features** (line appropriateness, cross-resistance, sequencing fitness)
- âœ… **Biomarker Gating** (HRD+, TP53 status, TMB â†’ personalized verdicts)
- âœ… **MoA Validation** (does compound mechanism align with tumor biology?)
- âœ… **Dynamic Discovery** (works for ANY compound, not hardcoded list)

---

## **ğŸ¯ CORE INNOVATION: EVO2 BIOLOGICAL PLAUSIBILITY**

### **The Problem:**
Anyone can search PubMed for "turmeric cancer" and get 50+ papers. But **NO tool can predict IF turmeric will actually work** for a specific patient.

### **Our Solution:**
Use **Evo2's sequence-level understanding** to score:
1. **Baseline:** How active is the target gene in the patient's disease context?
2. **Intervention:** How does the compound modulate that gene?
3. **Delta:** Is the biological impact significant enough to matter?

### **Example: Vitamin D + Ayesha (TP53 R248Q, HRD+)**

**Traditional Search:**
- Found: Multiple RCTs with mixed results
- Evidence Grade: MODERATE
- **Missing:** "But will it work for HER specific mutations?"

**Our Evo2 Analysis:**
```
ğŸ“Š BIOLOGICAL PLAUSIBILITY ANALYSIS

Target: VDR (Vitamin D Receptor) â†’ TP53 pathway
Disease: Ovarian cancer (TP53 R248Q, HRD+)

Evo2 Scores:
- Baseline: TP53 pathway activity = 0.15 (broken by R248Q)
- Post-Vitamin D: VDR activation â†’ TP53 rescue = 0.35
- Delta: +0.20 (MODERATE plausibility)

Verdict: "May partially restore p53 function via VDR"
Overall Score: 0.52 (WEAK_SUPPORT)
Confidence: 0.68 (MODERATE-HIGH due to HRD+ biomarker match)
```

**This is IMPOSSIBLE with just literature search!**

---

## **ğŸ—ï¸ ARCHITECTURE OVERVIEW**

```
User Query: "Can Vitamin D help my ovarian cancer?"
    â†“
[1] Dynamic Target Extraction
    â†’ Check food_targets.json
    â†’ Query ChEMBL (if not found)
    â†’ Extract from PubMed literature (LLM)
    â†’ Result: ["VDR", "TP53"]
    â†“
[2] Evo2 Biological Plausibility (if use_evo2=True)
    â†’ Fetch VDR gene sequence
    â†’ Score baseline disease-active state
    â†’ Score post-Vitamin D intervention
    â†’ Compute delta = plausibility score
    â†’ Result: overall_plausibility = 0.45, verdict = "MODERATE"
    â†“
[3] S/P/E Integration
    â†’ Sequence (S): Evo2 plausibility (0.45)
    â†’ Pathway (P): VDR signaling aligns with DNA repair (0.85)
    â†’ Evidence (E): Literature grade = "MODERATE" (0.60)
    â†’ Aggregate: overall_score = 0.61
    â†“
[4] SAE Treatment Line Features (if treatment_history provided)
    â†’ Line appropriateness: 1.0 (perfect for L3 post-platinum)
    â†’ Cross-resistance: 0.0 (no overlap with prior therapies)
    â†’ Sequencing fitness: 0.9 (supports next-line chemo)
    â†“
[5] Confidence Modulation
    â†’ Base: 0.60 (S/P/E average)
    â†’ Evo2 boost: +0.10 (HIGH plausibility targets)
    â†’ SAE boost: +0.05 (high line appropriateness)
    â†’ Biomarker boost: +0.05 (HRD+ â†’ DNA repair pathway match)
    â†’ Final: 0.80 (HIGH confidence)
    â†“
[6] LLM Literature Enhancement (if use_llm=True)
    â†’ Search PubMed: "Vitamin D AND ovarian cancer"
    â†’ Extract papers, synthesize evidence
    â†’ Result: 15 papers, confidence boost +0.15
    â†“
[7] Verdict Classification
    â†’ overall_score: 0.61, confidence: 0.80
    â†’ Verdict: "SUPPORTED" (score â‰¥0.65 AND confidence â‰¥0.70)
    â†’ Recommendation: "âœ… RECOMMENDED: Strong biological plausibility..."
```

---

## **ğŸ“¦ COMPONENT BREAKDOWN**

### **Backend Services:**
1. **`evo2_food_plausibility.py`** - Evo2 biological plausibility scoring
2. **`food_spe_integration.py`** - S/P/E + SAE aggregation
3. **`compound_target_extraction.py`** - Dynamic target discovery

### **API Endpoints:**
- `POST /api/hypothesis/validate_food_complete` - Main validation endpoint

### **Frontend Components:**
- `FoodValidatorAB.jsx` - Enhanced with Evo2 + S/P/E + SAE display
- `AyeshaTwinDemo.jsx` - Updated to test ALL compounds

---

## **ğŸ¯ VALUE PROPOSITION**

**For Ayesha (and any patient):**
- "Will this compound actually work for ME?" (not just "does literature say it might work?")
- Patient-specific recommendations based on mutations, biomarkers, treatment history
- Timing optimization: "When should I take this in my treatment sequence?"

**For Research/Clinical Use:**
- Mechanistic validation beyond literature
- Biomarker-aware recommendations
- Treatment line intelligence (SAE features)
- Transparent provenance (full audit trail)

---

## **âš”ï¸ DIFFERENTIATION SUMMARY**

| Feature | PubMed/Google Scholar | Our Tool |
|---------|----------------------|----------|
| Literature Search | âœ… | âœ… |
| Evidence Synthesis | âŒ | âœ… (LLM) |
| Biological Plausibility | âŒ | âœ… (Evo2) |
| Patient-Specific | âŒ | âœ… (mutations/biomarkers) |
| Treatment Line Intelligence | âŒ | âœ… (SAE features) |
| Works for ANY Compound | âŒ | âœ… (dynamic extraction) |
| S/P/E Integration | âŒ | âœ… |
| Confidence Modulation | âŒ | âœ… (multi-stage) |

**Result:** The ONLY tool that can **predict IF a compound will work**, not just what the literature says.

---

**Next Steps:** See [`phases/PHASE1_EVO2_PLAUSIBILITY.md`](./phases/PHASE1_EVO2_PLAUSIBILITY.md) to start building.

